NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...
IRVINE, CA--(Marketwired - Jul 31, 2013) - Masimo (NASDAQ: MASI) today announced that Masimo SET ® pulse oximetry is now being used hospital-wide in eight of the top10 hospitals on the current U.S.
About a year after beginning its full market launch, Masimo’s W1 smartwatch can now be used as a medical device in the U.S. The wearable device has earned FDA clearance for its medical applications, ...
Masimo (NASDAQ: MASI) today announced the CE Mark and full market release of MightySat™ Rx fingertip pulse oximeter for clinical use in CE countries, offering the same Masimo SET ® Measure-Through ...
The latest legal dispute between Apple and pulse oximetry company Masimo today ended in a mistrial, reports Bloomberg. The jury overseeing the case was not able to come to a final decision in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback